Background: Patients' health beliefs are essential to improve medication adherence among patients with hypertension. Objective: Our objective was to examine the relationship between (1) patients' beliefs about hypertension, medication, and self-efficacy and medication adherence and (2) medication adherence and blood pressure control in Oman. Methods: This cross-sectional study included 215 participants with hypertension. Participants completed 4 questionnaires (Arabic version) to measure medication adherence, beliefs about hypertension severity, beliefs about medication, and self-efficacy. Bivariate and multivariate logistic regression was used to conduct the analyses. Results: Higher self-efficacy (odds ratio [OR], 2.59; 95% confidence interval [CI], 1.54Y4.37), stronger beliefs about medication necessity (OR, 1.98; 95% CI, 1.21Y3.23), increased age (OR, 1.06; 95% CI, 1.03Y1.10), and fewer medication concerns (OR, 0.34; 95% CI, 0.20Y0.57) were related to high medication adherence. Moreover, uncontrolled blood pressure was less likely in participants with high medication adherence (OR, 0.47; 95% CI, 0.24Y0.93). Conclusions: Patients' beliefs are important consideration to improve medication adherence. Clinically, patients' beliefs should be assessed, and strategies to improve medication adherence should incorporate beliefs as a key component to improve antihypertensive medication adherence. Patient education and counseling regarding hypertension and necessity and side effects of medications are important to maximize positive beliefs and improve medication adherence.
Various factors contribute to poor medication adherence, 9 ,10 such as patients' beliefs, 9, 11 purposely skipping medication, forgetfulness, poor patient-provider communication, or access to care issues. 12 The Health Belief Model (HBM) supports that a decision to take a health action (ie, medication adherence) is influenced by patients' beliefs about the disease, effectiveness of medications, and self-efficacy. 13, 14 Therefore, investigators commonly use the HBM to understand how patients' perceptions of severity, benefits, barriers, and self-efficacy affect medication adherence.
15Y18
In literature related to HTN 15, 19, 20 and literature among Arabs, 21Y23 it has also been reported that adherence is related to beliefs about medication necessity and concern. For instance, in Islamic culture, all Muslims believe in the central role of God in healing, which may influence their behavior toward managing illnesses. Accordingly, some Muslims may take medications, whereas others may not because they believe that illness is God's wish and only religious practices will heal them. 24 Oman is similar to other Arab/Muslim countries where people believe that illness and/or healing is connected to God. 25 In Oman, although several investigators have examined HTN prevalence and risk factors, 26Y28 in only 1 study in 2005 was adherence to antihypertensive medications examined. 29 However, to date, no investigators have examined medication adherence in relation to patients' beliefs nor have they used the HBM as a framework. Hence, guided by the HBM, this study was conducted to examine (a) patients' beliefs about HTN, medication, self-efficacy, and adherence to antihypertensive medication and (b) the relationship between patients' beliefs and medication adherence and between medication adherence and blood pressure (BP) control (Figure 1 ). Findings from this study will enhance identification of factors related to poor adherence among Omanis as compared with other populations, thus revealing challenges and opportunities to improve medication adherence and BP control.
Method

Design and Setting
This descriptive cross-sectional study was conducted in Oman. Subjects with HTN were recruited from primary healthcare settings (eg, health centers) around Oman. Those primary healthcare settings have on-site HTN clinics, which are operated at least once a week. Participants were recruited from various clinics of Ad Dhakhiliyah, North Ash Sharqiyah, Muscat, Ad Dhahirah, and North and South Al Batinah Governorates. The Omani government primarily finances the healthcare system, whereas the Ministry of Health is the main healthcare provider and regulator.
Sample Size
In our previously published pilot study, 30 the smallest correlation between medication adherence and patients' beliefs was r = 0.25; this would have required a sample size of 117 to have 80% power to detect a relationship at .05 2-sided significance. To be more conservative, we considered a smaller correlation of r = 0.22, which would have required a sample size of 156 to have 80% power to detect a relationship at .05 2-sided significance. We overrecruited participants to raise the total sample to 215, thereby allowing for as much as 27% missing data.
Inclusion and Exclusion Criteria
Inclusion criteria were Omanis diagnosed with HTN for at least 3 months, 21 years or older, and taking at least 1 antihypertensive medication. Ethical approval was obtained from the Omani Ministry of Health.
Participants attending clinic were screened for eligibility using a patient list obtained through electronic medical records. Eligible participants were initially approached by a nurse about participation. Willing participants were then contacted by the principal investigator (PI) who informed them about the study's purpose and asked them to sign an informed consent form. Participants were assured that participation was voluntary and refusal to participate would not affect their treatment. Participants completed a demographic sheet and self-reported questionnaires on medication adherence and beliefs. For participants with reading limitations, the study purpose and procedure were explained by the PI; participants were asked to write ''X'' if they could not sign, and then they were interviewed by the PI. Data related to current BP, past BP readings during 5 previous clinic visits, 3 months apart, and comorbidity burden were obtained through medical records. Data were collected from 25 health centers, representing 14 districts in 6 governorates, from October 2015 to January 2016. Permission to use all questionnaires described hereinafter was obtained from the main developers.
Instruments
Eight-Item Morisky Medication Adherence Scale
We used the Arabic version of the 8-Item Morisky Medication Adherence Scale (MMAS-8) to measure medication adherence. The MMAS-8 is a reliable and valid scale 31 and has been adopted in several languages, including Arabic. 22,23,32Y37 It comprises 8 items: 7 items with a yes/no response and the remaining item that is rated on a 5-point Likert scale (4, never, to 0, all the time). All items are summed, with the last item weighted by 1/4, giving a total sum MMAS-8 score ranging from 0 to 8, with higher scores reflecting higher adherence. A total score of 6 or more indicates high adherence. 31 In this study, Cronbach ! was .64, which was less than the acceptable value of .70. Item 7 (ie, feeling hassled about sticking to medications) had the lowest corrected itemtotal correlation (r = 0.28). This item was retained because, when it was deleted, the ! coefficient decreased to .62.
Beliefs about Medicines QuestionnaireYSpecific
We used the Arabic version of the Beliefs about Medicines Questionnaire (BMQ)YSpecific to measure participants' beliefs about medication. It comprised the BMQ-Necessity scale (BMQ-N) to assess beliefs about medications' necessity and the BMQ-Concern scale (BMQ-C) to assess participants' concerns about medication. The BMQ-N and BMQ-C had adequate reliability and validity, 38 including the Arabic version.
22,39Y42
Subscales were rated on a 5-point Likert scale (5, strongly agree, to 1, strongly disagree), with a mean score ranging from 1 to 5; a higher score represented stronger beliefs about the necessity or concerns. In our study, Cronbach !s for the BMQ-N and BMQ-C were .84 and .70, respectively.
Brief Illness Perception Questionnaire
We used the Brief Illness Perception Questionnaire (BIPQ) to measure beliefs about HTN severity. The BIPQ comprised 8 items and had adequate reliability and validity. 43 It was translated to Arabic according to international guidelines. 44Y46 In our study, Cronbach ! was .52, indicating low internal consistency. Consequently, we deleted item 7, which had a low item-total correlation, and increased the ! coefficient to .66. Therefore, we used the 7-item BIPQ for the analysis. Each item of the BIPQ was rated from 0 to 10, with a total summated score ranging from 0 to 70 and a higher score indicating strong beliefs about HTN severity.
Medication Adherence Self-Efficacy ScaleYRevised
We used the Medication Adherence Self-Efficacy ScaleY Revised (MASES-R) to assess the degree of participants' confidence in taking medications under certain circumstances. The MASES-R, comprising 13 items, was translated to Arabic following international guidelines.
44Y46
It is reliable and valid 47 and is rated on 4-point responses (1, not at all sure; 4, extremely sure), with a mean score ranging from 1 to 4 (with a higher score indicating higher self-efficacy). 47 In this study, the MASES-R Cronbach ! was .93.
Systolic BP, Diastolic BP, and Charlson Comorbidity Index
The systolic BP (SBP), diastolic BP (DBP), and Charlson Comorbidity Index (CCI) to collect data on comorbidities 48, 49 were obtained from electronic medical records. Blood pressure is considered controlled if SBP is less than 140 mm Hg and DBP is less than 90 mm Hg. 5 The CCI score was calculated by summing the total weights assigned, with a higher score indicating a higher comorbidity burden. Patients' demographic data that were collected are illustrated in Table 1 .
Analysis
Data were analyzed using SPSS version 23 (IBM Corp, Armonk, New York). Descriptive statistics of means and standard deviations were used for continuous variables; and frequency and percentages, for categorical variables. Bivariate logistic regression was used to examine the relationships of demographics, CCI, and beliefs (BMQ-N, BMQ-C, BIPQ, and MASES-R) with having high medication adherence (MMAS-8 Q 6). Then, multivariate logistic regression analysis using backward elimination based on the likelihood ratio was used to examine the independent effect of beliefs on medication adherence. Demographic variables significantly related to MMAS-8 in the bivariate analysis were adjusted by multiple logistic regression analysis. In addition, similar bivariate and multivariate logistic regression analyses were conducted to predict BP control and high medication adherence. A P G .05, a 95% confidence interval, and odds ratios (ORs) were used to report the statistical significance and estimates.
Results
A total of 215 participants were included in this study (mean [SD] age, 53.6 [13.1] years) ( Table 1 ). The mean (SD) SBP and DBP were 140.8 (19.1) and 81.3 (11.3) mm Hg, respectively, and only 36% (n = 78) had their BP controlled. The comorbidity burden was 1.6 (SD, 0.98), with most participants (64%) having HTN only and the remaining having concurrent comorbidities (eg, diabetes, myocardial infarction, heart failure, stroke).
The mean (SD) score of the MMAS was 6.4 (1.6), with 68% of the participants having high adherence. Reasons for nonadherence as reported by participants who could select more than 1 reason were (1) feeling well and having controlled BP (17%), (2) feeling hassled about sticking to BP medication (22%), (3) forgetting BP medication when leaving home (24%), and (4) forgetting to take medication (30%).
The mean (SD) score of the BIPQ was 25.8 (12.2). The total score ranged from 0 to 56, with the 75th percentile at 39, indicating that a large majority of the participants had a lower perception regarding HTN severity. Overall, 76% of the participants believed that HTN minimally affects their life, 83% believed that they have control over HTN, 77% experienced few or no symptoms from HTN, and 74% had less concern about HTN.
The mean (SD) score of the BMQ-N was 3.7 (0.86). Participants agreed that their current health (70%) and future health (54%) depended on BP medication, that their lives would be impossible without BP medication (64%), and that BP medication protects their health from getting worse (85%).
The mean (SD) score of the BMQ-C was 2.4 (0.8). Most participants were not concerned about medication disrupting their life (86%), bothered by side effects (70%), worried to take BP medication (69%), nor feared dependency (59%). However, approximately 51% were worried about medication long-term side effects.
The mean (SD) score of the MASES-R was 3.4 (0.71). Most participants were confident to take their BP medication when they were busy at home (70%), did not have any symptoms (67%), and took medication more than once a day (66%) and while traveling (65%). Only 58% and 48% of the participants were confident to take medication in public and when medications bring about the urge to urinate while away from home, respectively.
Relationship Between Medication Adherence, Beliefs, and BP Control
The bivariate logistic analysis showed that increased age, higher self-efficacy, stronger beliefs about medication necessity, and being a widow had significantly high medication adherence (ORs, 1.07, 3.39, 1.82, and 6.75, respectively). On the contrary, those with stronger beliefs about HTN severity and more concerns about medications were significantly less likely to have high adherence (OR, 0.96 and 0.30, respectively). In addition, educated participants were significantly more adherent than illiterates (OR, 0.36 and 0.24, respectively).
The variables that were significantly related to high adherence in the bivariate analysis were entered into multiple regression analysis. Of all the variables entered (MASES-R, BIPQ, BMQ-N, BMQ-C, age, education, and marital status), only 4 variables (MASES-R, BMQ-N, BMQ-C, and age) remained after backward elimination. This reduced model was statistically significant (# 2 4 = 84.4, P G .001; Table 2 ) and explained 48% of the variation in medication adherence level (Nagelkerke R 2 = 0.48). Self-efficacy, beliefs about medication necessity, and concerns about medication explained approximately 37% of the variation in medication adherence (Nagelkerke R 2 = 0.37). The model revealed that (a) participants with higher self-efficacy were 2.5 times more likely to have high adherence (OR, 2.59; P G .001), (b) those with stronger beliefs about medication necessity were twice as likely to have high adherence (OR, 1.98; P = .006), and (c) those more concerned about their medication were approximately one-third as likely to have high adherence (OR, 0.34; P G .001). In addition, high adherence is more likely to increase with age (OR, 1.06; P G .001) (Figure 2) .
The bivariate logistic analysis between study variables and BP control showed that participants were significantly less likely to have uncontrolled BP with high medication adherence (OR, 0.50; P = .03) and more likely to have uncontrolled BP with more concerns 
Discussion
This study was conducted to examine the relationship between patients' beliefs and medication adherence among Omanis with HTN. The study found that Omani patients with HTN are more likely to have high medication adherence when they have stronger beliefs about medication necessity, stronger self-efficacy regarding medication adherence, and less concerns about medications. In addition, patients with higher adherence are less likely to have their BP uncontrolled. Higher adherence is reported among patients with stronger beliefs about medication necessity and less concerns about medication. These findings are consistent with HTN studies 15, 19, 20 and among Arabs.
21Y23
Approximately 50% of the participants reported concerns related to medications' side effects that could develop in the future. Therefore, it is essential for clinicians and scientists to assess patients' beliefs and concerns about medications to appropriately provide information emphasizing medications' benefits against future risks. As approximately 50% of our participants are unemployed/housewives and do not read or write, it is important to provide an effective and individualized health education to patients and their families. Accordingly, clinicians will be able to maximize positive medications' beliefs and minimize individual concerns to enhance adherence. Our findings regarding the positive relationship between self-efficacy and medication adherence are consistent with other studies in HTN, 20, 47, 52 glaucoma, 53 human immunodeficiency virus, 54 and osteoporosis. 55 These investigators reported the same positive association despite using different measures of adherence and self-efficacy. This is in line with Bandura's theory that supports self-efficacy as a central concept determining individuals' behaviors and how much effort they spend in adopting a healthy behavior. 56 This denotes the importance of incorporating self-efficacy into practice to increase patients' confidence in adopting management behaviors, particularly medication adherence. Accordingly, individualized care to enhance self-efficacy could be planned.
50,51
In Islamic culture, Muslims trust and depend on God for healing but, at the same time, they believe that health is a gift and they are responsible for protecting their health and seeking treatment. 57, 58 Hence, they make a maximal effort to seek care and leave the outcome to God. This could explain why our participants who believed that HTN minimally affected their life (76%) still felt that taking the medication was important to their current and future health (54%Y70%). Understanding these certain beliefs is crucial for healthcare providers taking care of Muslim patients. Furthermore, our participants reported less confidence in taking medications when they were in public or when medications caused frequent urination while away from home. This response is not unusual because Omanis value confidentiality and do not like to reveal their medical or personal issues to others, which could explain their lower confidence in taking medications under these circumstances.
Consistent with previous studies, participants with high medication adherence significantly exhibited more BP control. 31, 32, 59, 60 Behavioral and educational intervention studies have shown that improving patients' knowledge about HTN, its consequences, and medications' side effects improved medication adherence and BP outcomes. 61 Hence, the public health agenda could embrace assessing and improving adherence to antihypertensive medications as a top priority, given the high prevalence of HTN and uncontrolled BP worldwide and in Oman.
In this study, 68% of the subjects reported high adherence. Although this percentage is not optimal, it is higher compared with those of other countries in the Middle East. For instance, among Arabs, adherence ranged between 19% and 57%. 15, 22, 23, 35, 62 The higher adherence rate in our study could be attributed to the fact that 75% of the participants were 45 years or older and older age (eg, 950 years) has been significantly related to higher adherence. 22, 35, 60 Another explanation for higher adherence could be the fact that all Omanis have free access to medications and therefore cost would not be a barrier to adherence.
The findings of this study offered important implications for providers and researchers. Providers need to be aware that evaluating patients' beliefs is an important step toward improving medication adherence. Researchers should design interventions aiming to improve medication adherence through enhancing patients' awareness of medication necessity over medication concerns and individualized self-efficacy, which could be achieved through patient education about HTN and medication. Future studies are needed to validate the BIPQ and MMAS-8 in the Omani population and examine long-term medication adherence in Oman and in the Middle Eastern countries. Further studies could consider the effect of medication's class and dose and the effect of other medications used to treat concurrent comorbidities on medication adherence.
Our findings should be interpreted in light of several limitations. First, this study is cross-sectional and cannot support a causal relationship. Second, we used a self-reporting measure of adherence, which may have introduced a recall bias. However, the MMAS-8 is reliable, valid, and widely used across cultures and populations and has been correlated with objective measures of medication adherence (ie, pharmacy refills and electronic monitoring system). 63, 64 We used a convenience sample, which limited the generalizability of findings. Another limitation was the low reliability of the BIPQ and MMAS-8 (Cronbach !s = .66 and .62, respectively). However, both the BIPQ and MMAS-8 are widely used to measure perception of illness severity and medication adherence. Therefore, further studies to validate MMAS-8 and BIPQ among the Omani population could be conducted. In this study, we did not examine types or the actual dose of antihypertensive medications nor numbers and types of other medications taken to manage other concurrent comorbidities in relation to medication adherence. This could have influenced patients' beliefs about the necessity of and concerns regarding antihypertensive medications and medication adherence.
Conclusion
The study authors are the first to examine the relationship between beliefs and medication adherence in Oman using multiple cities and governorates. The study findings set new priorities for future research in Oman to incorporate patients' beliefs as a key aspect in providing health education and optimizing medication adherence among Arab patients.
h Higher adherence to antihypertensive medications is more likely with higher self-efficacy. h Stronger beliefs about medication necessity and less medication concerns are related to higher medication adherence. h Uncontrolled BP is less likely with high medication adherers.
